M1 Kliniken (M12) Stock Overview
Provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
M12 Community Fair Values
Create NarrativeSee what 21 others think this stock is worth. Follow their fair value or set your own to get alerts.
M1 Kliniken AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €17.86 |
| 52 Week High | €19.76 |
| 52 Week Low | €12.78 |
| Beta | 1.02 |
| 1 Month Change | 12.33% |
| 3 Month Change | 27.57% |
| 1 Year Change | 9.91% |
| 3 Year Change | 123.25% |
| 5 Year Change | 98.00% |
| Change since IPO | 257.27% |
Recent News & Updates
M1 Kliniken AG's (ETR:M12) P/E Is Still On The Mark Following 32% Share Price Bounce
Dec 05
The Return Trends At M1 Kliniken (ETR:M12) Look Promising
Nov 21At €15.74, Is M1 Kliniken AG (ETR:M12) Worth Looking At Closely?
Oct 14Solid Earnings Reflect M1 Kliniken's (ETR:M12) Strength As A Business
Jun 13Recent updates
M1 Kliniken AG's (ETR:M12) P/E Is Still On The Mark Following 32% Share Price Bounce
Dec 05The Return Trends At M1 Kliniken (ETR:M12) Look Promising
Nov 21At €15.74, Is M1 Kliniken AG (ETR:M12) Worth Looking At Closely?
Oct 14Solid Earnings Reflect M1 Kliniken's (ETR:M12) Strength As A Business
Jun 13M1 Kliniken's (ETR:M12) Dividend Will Be €0.50
May 24Does M1 Kliniken (ETR:M12) Have A Healthy Balance Sheet?
Oct 15Earnings Not Telling The Story For M1 Kliniken AG (ETR:M12) After Shares Rise 27%
Sep 24Why We're Not Concerned Yet About M1 Kliniken AG's (ETR:M12) 27% Share Price Plunge
Aug 03Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings
Jun 06M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump
May 29M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively
May 03At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?
Mar 07Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge
Feb 18Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?
Feb 17An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued
Sep 01Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?
Jun 01The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence
Mar 25Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital
Dec 17Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?
Nov 02Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook
May 26Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results
May 25Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital
Dec 06There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital
May 22Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like
Mar 19We're Watching These Trends At M1 Kliniken (ETR:M12)
Feb 21M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment
Feb 03
Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?
Jan 16M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Dec 29Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 14When Should You Buy M1 Kliniken AG (ETR:M12)?
Nov 28Shareholder Returns
| M12 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0.9% | 0.7% | 0.08% |
| 1Y | 9.9% | 23.6% | 14.1% |
Return vs Industry: M12 underperformed the German Healthcare industry which returned 23.6% over the past year.
Return vs Market: M12 underperformed the German Market which returned 14.1% over the past year.
Price Volatility
| M12 volatility | |
|---|---|
| M12 Average Weekly Movement | 7.4% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in DE Market | 12.0% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: M12 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: M12's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 199 | Attila Strauss | www.m1-kliniken.de |
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; abdominoplastic and nose correction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin.
M1 Kliniken AG Fundamentals Summary
| M12 fundamental statistics | |
|---|---|
| Market cap | €330.28m |
| Earnings (TTM) | €17.74m |
| Revenue (TTM) | €354.98m |
Is M12 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| M12 income statement (TTM) | |
|---|---|
| Revenue | €354.98m |
| Cost of Revenue | €307.41m |
| Gross Profit | €47.57m |
| Other Expenses | €29.83m |
| Earnings | €17.74m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.96 |
| Gross Margin | 13.40% |
| Net Profit Margin | 5.00% |
| Debt/Equity Ratio | 6.4% |
How did M12 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/23 19:27 |
| End of Day Share Price | 2025/12/23 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
M1 Kliniken AG is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Charlotte Friedrichs | Berenberg |
| Ellis Acklin | First Berlin Equity Research GmbH |
| Alexander Galitsa | Hauck Aufhäuser Investment Banking |